BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 19987362)

  • 61. [On the appearance of the eye fundus in polycythaemia vera (author's transl)].
    Mailáth L; Nagy G; Gát G; Rácz
    Klin Monbl Augenheilkd; 1976 Sep; 169(3):343-8. PubMed ID: 1003824
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV): a randomised, non-inferiority, phase 3 trial and its extension study.
    Gisslinger H; Klade C; Georgiev P; Krochmalczyk D; Gercheva-Kyuchukova L; Egyed M; Rossiev V; Dulicek P; Illes A; Pylypenko H; Sivcheva L; Mayer J; Yablokova V; Krejcy K; Grohmann-Izay B; Hasselbalch HC; Kralovics R; Kiladjian JJ;
    Lancet Haematol; 2020 Mar; 7(3):e196-e208. PubMed ID: 32014125
    [TBL] [Abstract][Full Text] [Related]  

  • 63. ruxolitinib (JAKAVI°) and polycythaemia vera Inconclusive evaluation.
    Prescrire Int; 2016 Oct; 25(175):229-231. PubMed ID: 30645821
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Clinico-Pathological Profile And Outcomes Of Patients With Polycythaemia Vera, Essential Thrombocythaemia And Idiopathic Myelofibrosis: A Tertiary Care Center Experience From Southern Pakistan.
    Shaikh MS; Shaikh MU; Adil SN; Khurshid M; Ahmed ZA
    J Ayub Med Coll Abbottabad; 2016; 28(2):293-297. PubMed ID: 28718562
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The treatment of polycythaemia vera: an update in the JAK2 era.
    Finazzi G; Barbui T
    Intern Emerg Med; 2007 Mar; 2(1):13-8. PubMed ID: 17551678
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Myocardial infarction with proximal occlusion of the left anterior descending coronary artery in a 22-year-old patient with polycythaemia vera.
    Nahler A; Fuchs D; Reiter C; Kiblböck D; Steinwender C; Lambert T
    Clin Med (Lond); 2017 Feb; 17(1):46-47. PubMed ID: 28148580
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Coexistence of renal artery stenosis, primary antiphospholipid syndrome and polycythaemia vera: an exceptional association.
    Zahra Ha-ou-Nou F; Boumzebra D; Essaadouni L
    Lupus; 2014; 23(1):84-7. PubMed ID: 24197551
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Carbon monoxide diffusing capacity in polycythaemia rubra vera.
    Greening AP; Patel K; Goolden AW; Munro AJ; Hughes JM
    Thorax; 1982 Jul; 37(7):528-31. PubMed ID: 7135294
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Skin cancer in essential thrombocythaemia and polycythaemia vera patients treated with hydroxycarbamide.
    Mathur A; Edman J; Liang L; Scott NW; Watson HG
    EJHaem; 2022 Nov; 3(4):1305-1309. PubMed ID: 36467813
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Long-term cultures in polycythaemia vera as proof for dependence on erythropoietin (author's transl)].
    Heilmann E; Holzknecht A; Fahrenkrug H; Essers U
    Blut; 1981 Jul; 43(1):51-6. PubMed ID: 7260404
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Urticarial vasculitis associated with polycythaemia rubra vera.
    Farell AM; Sabroe RA; Bunker CB
    Clin Exp Dermatol; 1996 Jul; 21(4):302-4. PubMed ID: 8959906
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Masked polycythaemia vera is genetically intermediate between JAK2V617F mutated essential thrombocythaemia and overt polycythaemia vera.
    Tiong IS; Casolari DA; Nguyen T; Van Velzen MJ; Ambler K; D'Andrea RJ; Ross DM
    Blood Cancer J; 2016 Aug; 6(8):e459. PubMed ID: 27540717
    [No Abstract]   [Full Text] [Related]  

  • 73. Extramedullary haemopoietic tumours complicating polycythaemia vera.
    MacCallum PK; Newbould MJ; Sambrook PS; Burton IE
    J Clin Pathol; 1988 Jun; 41(6):609-14. PubMed ID: 3164326
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Different lymphocyte activity in patients with polycythaemia vera versus secondary polycythaemia and healthy blood donors.
    Rueda F; Remacha A; Martí F; Piñol G; Soler J; Guañabens C; Gimferrer E
    Acta Haematol; 1990; 83(1):31-4. PubMed ID: 1967891
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Improving the investigative approach to polycythaemia vera: a critical assessment of current evidence and vision for the future.
    Ronner L; Venugopal S; Moshier E; Mascarenhas J
    Lancet Haematol; 2021 Aug; 8(8):e605-e612. PubMed ID: 34329580
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Thrombocytosis, thrombocythaemia and iron deficiency in patients with polycythaemia vera.
    Shaw D; Tudhope GR
    Acta Haematol; 1979; 62(4):223-8. PubMed ID: 119415
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Coronary artery bypass grafting in a patient with polycythaemia rubra vera - a rare indication with a spectrum of complication: a case report.
    Al-Fadhli J; Al-Shammari F; Al-Duaij A; Al-Sarraf N
    Cases J; 2009 Aug; 2():8126. PubMed ID: 19918456
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Clinics in diagnostic imaging (146). Polycythaemia vera (PV).
    Lim BK
    Singapore Med J; 2013 May; 54(5):289-91; quiz 292. PubMed ID: 23716157
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Polycythaemia vera.
    Devi SB; Sangma RN
    J Indian Med Assoc; 2002 Apr; 100(4):253. PubMed ID: 12405339
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Chorea disclosing deterioration of polycythaemia vera.
    Nazabal ER; Lopez JM; Perez PA; Del Corral PR
    Postgrad Med J; 2000 Oct; 76(900):658-9. PubMed ID: 11009585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.